Brivaracetam
CAS 357336-20-0
First came a useful drug, then its molecular target, then a stronger ligand. Brivaracetam is a clear example of mechanism guiding next-generation drug design.
Brivaracetam (CAS 357336-20-0) is a target-guided successor to levetiracetam. Understanding SV2A turned an unusual antiseizure observation into a systematic medicinal-chemistry program.
Published:
2026-09-18
